Dr. Ricardo Goncalves Alvim, MD

Dr. Alvim practices at UPMC Jameson in New Castle, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Alvim's NPI, 1902464324, was assigned on May 31, 2019. Dr. Alvim holds Pennsylvania license MD470983.

Dr. Alvim's primary practice is UPMC Jameson, at 1211 Wilmington Avenue, New Castle, PA 16105 in Lawrence County. The practice phone is (724) 656-4100.

Dr. Alvim's primary practice is UPMC Jameson in New Castle, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Alvim is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Alvim to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alvim practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Alvim's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Alvim's licenses on file in 2 states: Pennsylvania and New York.

CMS data shows 742 Medicare services from Dr. Alvim across 12 procedure codes in 2024, for 214 Medicare patients. Medicare paid $41,078 for them.

CMS counts 214 Medicare patients who saw Dr. Alvim in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alvim's median patient age at 73, with 30% women.

In 2024, Dr. Alvim wrote 666 Medicare Part D claims for 203 patients. 93% of them were for generic drugs. CMS names the drug for 601 of them, across 9 drugs with 11 or more claims each, at $27,597 in total drug cost. In 2023, CMS named 596 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Alvim for performance year 2024, reported as part of a group. Dr. Alvim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alvim as offering telehealth. CMS counts 31 procedures of prostate resection by Dr. Alvim, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 23 papers to Dr. Alvim, published from 2018 to 2024. 2019 was the busiest year, with 8. The most frequent topics are Photochemotherapy, Prostatic Neoplasms and Urinary Bladder Neoplasms. Dr. Alvim has published most often in J Urol. Dr. Alvim's most frequent co-authors are Jonathan Andrew Coleman, MD, Kwanghee Kim, MD and Nathan Colin Wong, MD.

CMS Open Payments shows 24 general payments to Dr. Alvim from 4 drug and device companies from 2022 to 2025. Travel and lodging make up the largest share, 66% of the total. Distalmotion US paid the most, $2,386.